国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
23期
57-60
,共4页
王志艺%林松%陈火明%曾成林%Cheng lin
王誌藝%林鬆%陳火明%曾成林%Cheng lin
왕지예%림송%진화명%증성림%Cheng lin
脑梗死%β-七叶皂甙钠%C-反应蛋白
腦梗死%β-七葉皂甙鈉%C-反應蛋白
뇌경사%β-칠협조대납%C-반응단백
Cerebral infarction%Sodium 3 -Aescinate%C-reactive protein
目的 通过观察急性脑梗死患者使用β-七叶皂甙钠前后血清高敏感C-反应蛋白的水平的变化,探讨β-七叶皂甙钠在急性脑梗死治疗中的抗炎作用.方法 选择100例急性脑梗死患者,患者随机分为治疗组和对照组各50例,治疗组给予β-七叶皂甙钠20mg/d静滴,其他用药同对照组,对照组每天静脉应用丹参注射液、胞二液胆碱等药物,应用放射免疫比浊法检测治疗前、治疗后3d、7d、14d的血清hs-CRP水平变化,并进行神经功能缺损标准评分(CSS).结果 两组患者在脑梗死后3天hs-CRP水平最高,随后渐降低,治疗后7d治疗组hs-CRP水平明显低于对照组,差异有显著性(P<0.05).14d治疗组神经功能缺损明显优于对照组,差异有极显著性(P<0.01).结论 β-七叶皂甙钠在急性脑梗死患者治疗中可以降低患者血清hs-CRP水平.有利于减轻炎症反应,改善脑梗死缺血缺氧和缺损的神经功能.
目的 通過觀察急性腦梗死患者使用β-七葉皂甙鈉前後血清高敏感C-反應蛋白的水平的變化,探討β-七葉皂甙鈉在急性腦梗死治療中的抗炎作用.方法 選擇100例急性腦梗死患者,患者隨機分為治療組和對照組各50例,治療組給予β-七葉皂甙鈉20mg/d靜滴,其他用藥同對照組,對照組每天靜脈應用丹參註射液、胞二液膽堿等藥物,應用放射免疫比濁法檢測治療前、治療後3d、7d、14d的血清hs-CRP水平變化,併進行神經功能缺損標準評分(CSS).結果 兩組患者在腦梗死後3天hs-CRP水平最高,隨後漸降低,治療後7d治療組hs-CRP水平明顯低于對照組,差異有顯著性(P<0.05).14d治療組神經功能缺損明顯優于對照組,差異有極顯著性(P<0.01).結論 β-七葉皂甙鈉在急性腦梗死患者治療中可以降低患者血清hs-CRP水平.有利于減輕炎癥反應,改善腦梗死缺血缺氧和缺損的神經功能.
목적 통과관찰급성뇌경사환자사용β-칠협조대납전후혈청고민감C-반응단백적수평적변화,탐토β-칠협조대납재급성뇌경사치료중적항염작용.방법 선택100례급성뇌경사환자,환자수궤분위치료조화대조조각50례,치료조급여β-칠협조대납20mg/d정적,기타용약동대조조,대조조매천정맥응용단삼주사액、포이액담감등약물,응용방사면역비탁법검측치료전、치료후3d、7d、14d적혈청hs-CRP수평변화,병진행신경공능결손표준평분(CSS).결과 량조환자재뇌경사후3천hs-CRP수평최고,수후점강저,치료후7d치료조hs-CRP수평명현저우대조조,차이유현저성(P<0.05).14d치료조신경공능결손명현우우대조조,차이유겁현저성(P<0.01).결론 β-칠협조대납재급성뇌경사환자치료중가이강저환자혈청hs-CRP수평.유리우감경염증반응,개선뇌경사결혈결양화결손적신경공능.
Objective To investigate the relationship between sodium aescinate and serum high sensitity C-reactive protein (hs-CRP) in the patients with acute cerebral infarction.Methods 100 patients with cerebral farction were divided into two groups randomly.In the treatment group(n=50),the patientnts were given Sodium fj -Aescinate 20mg/d by IV instillation qd.Conventional treatment for patients of both groups was the same except for Sodium p -Aescinate.Patients of the control group were given Danshen Injection,CDPC by IV instillation qd.The course of the treatment in the two groups lasted for 14 days.The neurologic impairment scores were noted down and concentrations of soluble hs-CRP before the treatment and on the 3rd day ,7th day and the 14th d after the treatment .The level of serum hs-CRP was measured by scatter immune turbidity method.Results hs-CRP reached the highest level on the 3rd day and then decreased slowly .The decline in serum level of hs-CRP on the 7th day after the treatment was more striking in patients of the treatment group than that of the control group (P < 0.05).The decline of he neurologic impairment scores on the 14th day after the treatment was more striking in the patients of the treatment group than that of the control group (P < 0.01). Conclusions Sodium p -Aescinate can decrease the density of the serum hs-CRP and the inflammatory reaction.lt meas that Sodium P -Aescinate can play an important roel in protecting brain cells and blood ressel endothelial cells.and decrease the inflammatory redion.